Company Valuation: Kobayashi Pharmaceutical Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 704,427 650,295 503,841 463,131 403,511 415,405 - -
Change - -7.68% -22.52% -8.08% -12.87% 2.95% - -
Enterprise Value (EV) 1 596,011 546,554 424,992 398,232 333,575 349,401 345,176 339,304
Change - -8.3% -22.24% -6.3% -16.24% 4.74% -1.21% -1.7%
P/E 35.8x 34.8x 25.3x 46x 110x 39.9x 30.6x 24.8x
PBR 3.59x 3.47x 2.47x 2.18x 1.92x 1.97x 1.92x 1.86x
PEG - 12.08x 7.7x -0.9x -1.7x 0x 1x 1.1x
Capitalization / Revenue 4.54x 3.91x 2.9x 2.8x 2.43x 2.41x 2.31x 2.23x
EV / Revenue 3.84x 3.29x 2.45x 2.4x 2.01x 2.03x 1.92x 1.82x
EV / EBITDA 19.3x 17.1x 13.3x 12.1x 14.1x 15.3x 12.8x 10.9x
EV / EBIT 22.9x 20.5x 16.5x 16x 22.4x 26.2x 19.7x 15.8x
EV / FCF 31.8x 31.1x -350x -29.2x 68.5x 23.5x 22.7x 19.7x
FCF Yield 3.15% 3.22% -0.29% -3.42% 1.46% 4.25% 4.4% 5.07%
Dividend per Share 2 83 90 101 102 104 106 109.5 114.3
Rate of return 0.92% 1% 1.49% 1.64% 1.92% 1.9% 1.96% 2.05%
EPS 2 252.4 259.6 268.2 135.4 49.19 140.1 182.5 225.4
Distribution rate 32.9% 34.7% 37.7% 75.3% 211% 75.7% 60% 50.7%
Net sales 1 155,252 166,258 173,455 165,600 165,742 172,508 179,820 186,639
EBITDA 1 30,900 32,027 31,837 32,800 23,600 22,780 27,030 31,262
EBIT 1 26,065 26,669 25,780 24,860 14,923 13,355 17,494 21,464
Net income 1 19,715 20,022 20,338 10,067 3,656 10,520 13,674 16,493
Net Debt 1 -108,416 -103,741 -78,849 -64,899 -69,936 -66,004 -70,229 -76,101
Reference price 2 9,040.00 9,030.00 6,790.00 6,230.00 5,428.00 5,588.00 5,588.00 5,588.00
Nbr of stocks (in thousands) 77,923 72,015 74,203 74,339 74,339 74,339 - -
Announcement Date 04/02/22 14/02/23 09/02/24 10/02/25 10/02/26 - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
39.9x2.03x15.34x1.9% 2.61B
21.28x4.14x15.18x2.95% 336B
18.26x2.77x12.25x3.45% 137B
25.13x3.72x15.69x2.32% 72.78B
43.58x7.02x30.47x2.12% 51.72B
20.19x2.84x11.77x4.4% 36.94B
81.14x2.41x14.5x1.68% 30.35B
18.73x1.37x8.17x1.26% 20.29B
15.99x1.54x8.76x3.31% 19.7B
21.65x1.56x9.96x2.39% 18.55B
Average 30.59x 2.94x 14.21x 2.58% 72.69B
Weighted average by Cap. 24.99x 3.69x 15.06x 2.89%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 4967 Stock
  4. Valuation Kobayashi Pharmaceutical Co., Ltd.